ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,172.50
0.61%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) Noticias

LAB Standard BioTools Inc

2.34
-0.07 (-2.90%)
10 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Standard BioTools Inc LAB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.07 -2.90% 2.34 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.40 2.38 2.47 2.40 2.41
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/5/202416:16EDGAR2Form PREC14A - Preliminary proxy statements, contested..
09/5/202415:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:31EDGAR2Form 8-K - Current report
08/5/202415:01GLOBEStandard BioTools Reports First Quarter 2024 Financial..
25/4/202407:01GLOBEStandard BioTools Announces Operational Restructuring Plan..
25/4/202407:00GLOBEStandard BioTools Announces Conference Call and Webcast for..
08/4/202407:00GLOBEStandard BioTools Introduces New High-Throughput Multiplexed..
03/4/202415:01GLOBEStandard BioTools Announces Multi-Year Strategic Engagement..
18/3/202407:12GLOBEStandard BioTools Announces Exchange of All Outstanding..
06/3/202418:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202415:05EDGAR2Form 8-K - Current report
28/2/202415:01GLOBEStandard BioTools Reports Fourth Quarter and Full Year 2023..
26/2/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/2/202407:00GLOBEStandard BioTools and Next Gen Diagnostics Announce..
22/2/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202415:05GLOBEStandard BioTools to Participate in Upcoming Investor..
14/2/202414:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:30GLOBEStandard BioTools Announces Conference Call and Webcast for..
07/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
07/2/202407:30GLOBEStandard BioTools and Navignostics Announce Collaboration..
02/2/202415:49EDGAR2Form S-3/A - Registration statement under Securities Act of..
19/1/202416:07EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202416:05EDGAR2Form S-3 - Registration statement under Securities Act of..
19/1/202416:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202415:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202415:33EDGAR2Form 8-K/A - Current report: [Amend]
12/1/202413:04EDGAR2Form SC 13D/A - General statement of acquisition of..
09/1/202419:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202417:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202417:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/1/202416:13EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202416:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/1/202407:39EDGAR2Form 8-K - Current report
08/1/202407:30GLOBEStandard BioTools Announces Preliminary Fourth Quarter and..
05/1/202407:53EDGAR2Form 8-K - Current report
05/1/202407:46GLOBEStandard BioTools Completes Merger with SomaLogic, Creating..
04/1/202421:23GLOBEStandard BioTools Stockholders Approve Merger with SomaLogic
04/1/202420:44PRNUSSomaLogic Stockholders Vote to Approve Standard BioTools..
29/12/202316:26EDGAR2Form 425 - Prospectuses and communications, business..
29/12/202316:25EDGAR2Form 8-K - Current report
29/12/202316:04GLOBEGlass Lewis Recommends Standard BioTools Stockholders Vote..
28/12/202315:16PRNUSDr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to..
26/12/202314:59PRNUSSomaLogic Issues Statement Correcting Madryn Asset..
22/12/202317:57GLOBEISS Recommends Standard BioTools Stockholders Vote “FOR” All..
21/12/202307:00GLOBESomaLogic Issues Letter to Stockholders Reiterating..

Su Consulta Reciente

NASDAQ
LAB
Standard BioTools
BTRX
BNTETH
Bancor
EU
MLMAD
Made
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados